PharmGen Science Inc Defensive Interval Ratio

Latest as of September 2025: 392 days

PharmGen Science Inc defensive interval ratio. PharmGen Science Inc (004720) has a Defensive Interval Ratio of 392 days as of September 2025. Defensive assets of ₩44.82 Billion (cash ₩-, short-term investments ₩533.30 Million, receivables ₩44.29 Billion) cover 392 days of daily cash needs of ₩114.39 Million/day. Explore 004720 long-term investment intensity to see how much of total assets are deployed in long-term investments.

Defensive Interval Ratio

392 days
Days of operational coverage

Defensive Assets

₩44.82 Billion
Cash + ST Investments + Receivables

Daily Cash Need

₩114.39 Million
Current Liabilities ÷ 365

Current Liabilities

₩41.75 Billion
KRW

Defensive Interval Ratio of PharmGen Science Inc (2004–2024)

Defensive interval ratio of PharmGen Science Inc from 2004 to 2024. This chart shows how PharmGen Science Inc's Defensive Interval Ratio has evolved across 17 annual periods from 2004 to 2024. As of September 2025, the ratio stands at 392 days, meaning defensive assets of ₩44.82 Billion can fund 392 days of operations without new revenue. Read 004720 total debt and obligations for a breakdown of total debt and financial obligations.

PharmGen Science Inc Defensive Interval Ratio by Year (2004–2024)

PharmGen Science Inc defensive interval ratio by year from 2004 to 2024. The table below presents the year-by-year Defensive Interval Ratio for PharmGen Science Inc from 2004 to 2024, covering 17 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see how large is PharmGen Science Inc's balance sheet.

Year DIR (days) Defensive Assets (KRW) Daily Cash Need Cash ST Investments Change (days)
2024 222 days ₩39.83 Billion ₩179.24 Million/day ₩- ₩532.57 Million ▲ +13 days
2023 209 days ₩36.15 Billion ₩173.07 Million/day ₩- ₩531.85 Million ▲ +56 days
2022 153 days ₩28.57 Billion ₩186.81 Million/day ₩- ₩531.28 Million ▲ +48 days
2021 105 days ₩20.39 Billion ₩194.85 Million/day ₩- ₩531.09 Million ▼ -147 days
2020 251 days ₩25.94 Billion ₩103.25 Million/day ₩- ₩4.53 Billion ▼ -37 days
2019 288 days ₩23.92 Billion ₩83.12 Million/day ₩- ₩4.53 Billion ▼ -188 days
2018 475 days ₩42.93 Billion ₩90.32 Million/day ₩- ₩23.53 Billion ▼ -845 days
2017 1320 days ₩36.48 Billion ₩27.63 Million/day ₩- ₩16.83 Billion ▲ +741 days
2016 579 days ₩34.67 Billion ₩59.87 Million/day ₩- ₩17.97 Billion ▼ -133 days
2015 712 days ₩24.98 Billion ₩35.08 Million/day ₩- ₩5.62 Billion ▲ +298 days
2014 414 days ₩20.06 Billion ₩48.44 Million/day ₩- ₩3.06 Billion ▼ -225 days
2013 639 days ₩21.11 Billion ₩33.02 Million/day ₩- ₩1.91 Billion ▲ +135 days
2012 504 days ₩18.92 Billion ₩37.52 Million/day ₩- ₩515.00 Million ▲ +152 days
2011 352 days ₩20.91 Billion ₩59.39 Million/day ₩- ₩704.04 Million ▲ +6 days
2005 346 days ₩25.09 Billion ₩72.55 Million/day ₩- ₩2.75 Billion ▲ +12 days
2004 334 days ₩20.33 Billion ₩60.96 Million/day ₩- ₩2.43 Billion ▲ +10 days
2004 323 days ₩20.23 Billion ₩62.59 Million/day ₩- ₩2.27 Billion —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)